![]() ![]() Teva Pharmaceutical Industries Limited (NYSE: TEVA) is the 25 th on the list of 25 biggest pharmaceutical companies in the world. Market Capitalization as of September 02, 2022: $10 billion Market Capitalization as of September 11, 2021: $10.3 billion Teva Pharmaceutical Industries Limited ( NYSE: TEVA) 25 Biggest Pharmaceutical Companies in the World 25. We rank the companies based on their market capitalization. With this context in mind, let's now discuss the 25 biggest pharmaceutical companies in the world. This change in the collective perspective of humanity ensures that the pharmaceutical industry would thrive in the coming years.Ģ5 Biggest Pharmaceutical Companies in the World Even as the rollout of COVID-19 vaccines gradually ensures that the entire human race is protected against the virus, people will remain especially conscious about their health for years to come. Consequently, healthcare and pharmaceutical companies are one of the fastest-growing industries presently. With the world adjusting to the new post-pandemic normal, people have developed hygienic habits and have become hyper-aware of their health. (NASDAQ: MRNA) increased by a noteworthy 5% when it released news about its COVID-19 vaccine being effective against the Delta variant of the virus. (NYSE: PFE) rose by 4.9% within a day following its report about the successful development of the COVID-19 vaccine. In the first quarter of 2021, activity levels in the industry were 14.6% higher than they were at the end of 2019.Īfter the vaccines had rolled out, pharmaceutical companies experienced massive success. In fact, the pharmaceutical industry’s activity in 2021 has improved to an even higher level than in the pre-pandemic months. However, the pharmaceutical industry was one of the first and fastest to recover. About Johnson & Johnson (NYSE: JNJ), Mario Gabelli commented “ Johnson & Johnson has the management team and the strong balance sheet to emerge from the current crisis in a stronger position than ever before.” The comment shows that the major players in the global pharmaceutical industry were expected to recover easily from any losses that they incurred during the coronavirus pandemic.Īlthough the pandemic had a different effect on each pharmaceutical company, the industry suffered overall. (NYSE: MRK)’s sales decreased by $2.1 billion due to the drastic drop in doctor’s office visits. (NYSE: PFE) reported a 12% drop in sales. While Bayer Aktiengesellschaft (OTC: BAYRY) experienced a 4.8% rise in sales during the pandemic due to the increased demand for drugs such as aspirin, Pfizer Inc. The pharmaceutical industry suffered due to the coronavirus, primarily due to the supply chain issues during the pandemic. Story continues Impact of the Coronavirus Thirdly, cloud technology has enabled pharmaceutical companies to partner with prominent stakeholders such as the government in order to secure their data as well as integrate the data of their customers, thereby enhancing its integrity. Moreover, the digitalization of processes ensures transparency and regulatory compliance in pharmaceutical companies. Secondly, the replacement of paper process by digital processes has minimized the chances of error and loss of data and have enhanced the operational efficiency in the industry. AI essentially accelerates the developmental journey of medicines, as it optimizes clinical trials and improves the process of mass production (see 11 best AI stocks to buy now). Firstly, the use of artificial intelligence helps companies with both the discovery and production of drugs. Changing Trends for the Pharmaceutical IndustryĪs with most other lucrative industries, technological innovation has changed the face of the pharmaceutical industry in recent years. (NYSE: PFE), and Abbott Laboratories (NYSE: ABT). The most prominent players in the global pharmaceutical market are GlaxoSmithKline plc (NYSE: GSK), Merck & Co., Inc. ![]() Moreover, in the years between 20, the pharmaceutical industry is forecasted to grow by a compound annual growth rate (CAGR) of 11.34%. The global pharmaceutical market stood at an impressive value of $1,270 billion by the end of the year 2020. The biggest loser in the list is probably Moderna (MRNA) which was riding high a year ago because of high expectations about its COVID vaccine. Most of the article was written a year ago and discuss what hedge funds thought about those companies at that time. In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today.
0 Comments
Leave a Reply. |